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Background: Posterior reversible encephalopathy syndrome is a presentation which is diagnosed clinico-
radiologically. The primary aetiological processes leading to posterior reversible encephalopathy syndrome are
many, which include autoimmune conditions. Polyarteritis nodosa as an aetiological factor for posterior reversible
encephalopathy syndrome is rare. We present a case of polyarteritis nodosa complicated by posterior reversible
encephalopathy syndrome.
Case presentation: A 26-year-old South-Asian female presented with left sided focal seizures with secondary
generalization and visual disturbance for 2 days duration. She had a prior history of arthralgia and weight loss with
no medically explainable cause for young onset hypertension. Examination revealed a right claw hand with a
palpable vasculitic type of rash involving both the palmar surfaces. Symptoms responded to management with
anti-hypertensives and anti-epileptics. Whole blood count, iron studies, erythrocyte sedimentation rate and
C-reactive protein values portrayed an ongoing chronic inflammatory process. Serological studies such as
Anti-nuclear antibody, Anti -double stranded deoxyribonucleic acid, Anti-neutrophil cytoplasmic antibody and
Anti-cyclic citrulinated peptide were negative. Magnetic resonance imaging revealed high signal intensity on T2 in
both occipital lobes. Skin biopsy of the palm revealed moderate vessel vasculitis. Renal imaging revealed structurally
abnormal kidneys with micro aneurysms in the right renal vasculature. Repeat magnetic resonance imaging of the
brain two months later showed marked improvement. A diagnosis of polyarteritis nodosa with posterior reversible
encephalopathy syndrome was made.
Conclusions: Posterior reversible encephalopathy syndrome should not be missed. Investigations for an
aetio-pathological cause should be considered including the rarer associations like polyarteritis nodosa.
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Posterior reversible encephalopathy syndrome (PRES) is
a neurotoxic state diagnosed clinico-radiologically. Be-
ing introduced in the mid-nineties, it has a classic reper-
toire of symptoms with alteration of vision, altered
mental state, new onset headache, seizures and findings
on brain imaging studies with typical magnetic reson-
ance imaging (MRI) and computed tomographic (CT)
changes [1]. Even though there is better understanding
of its various aetiological causes there is still doubt as to
its exact mechanism, and questions remain whether it is* Correspondence: rayno.navinan@gmail.com
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stated.hyper-perfusion in the presence of failed auto-regulation
with hypertension or endothelial cell dysfunction with re-
sultant vasoconstriction and hypo-perfusion that causes
the classic picture [2]. Toxic states in pregnancy, drugs
used for immune suppression and chemo therapy, post-
transplant, sepsis, and autoimmune conditions have been
associated with PRES [3]. Vasculitis is a known aetiology,
and is especially seen with a comparative high incidence
in systemic lupus erythematosus [4]. However, only a
handful of documented cases of polyarteritis nodosa(PAN)
with PRES have been reported [5-7]. The mostly benign
nature of the disease is demonstrated as there is complete
reversal of the clinical picture within days, with symptom-
atic and aetiologically focused treatment. Principles ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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zures, and treatment of the causative agent inducing PRES
[8]. Reversal of the imaging abnormalities occur anywhere
between days to months [1]. Polyarteritis nodosa is a mod-
erate vessel vasculitis that has no definitive diagnostic
investigation and the diagnosis is made when clinical cri-
teria are met of standard guidelines such as that of the
American College of Rheumatology (ACR) and completed
in the presence of either histological evidence or a typical
imaging abnormality in the renal arteriogram [9]. We
present a typical yet rare case of PAN with PRES.
Case presentation
A 26-year-old South-Asian female presented with a 6 day
history of disproportionately worsened episodic vomiting
on a backdrop of a 3 month history of oesophageal reflux
due to frequent non steroidal anti- inflammatory drug
(NSAID) use, a short two day history of new onset vis-
ual impairment with flashes of light, double vision and
altered behaviour followed by recurrent generalized
tonic-clonic seizures that had an initial focal origin from
the left lower limb.
In the preceding year she was investigated for probable
pyrexia of unknown origin twice in separate institutions
without being able to arrive at a conclusive diagnosis. Dur-
ing the span of one year the patient also noted a weight
loss of 8 kilos. She was also treated for eight months for
young onset hypertension, which poorly responded to
medical management (highest recorded value was 138/
110 mmHg, other readings showed fluctuations ranging
from 140/90 mmHg to acceptable levels of 110/70 mmHg)
even with good drug compliance. She was also diagnosed
as having sero-negative arthritis involving the left lower
limb knee and ankle and was treated with Non-steroidal
anti- inflammatory drugs for the same duration. Three
months prior to the presenting episode she developed
recurrent left sided loin pain which was diagnosed as a
urinary tract infection. For the similar 3 month duration
she developed recurrent episodes of vomiting which wasFigure 1 Claw hand and vasculitic rash: Image on the left depicts a p
the right depicts a right sided claw hand.diagnosed by upper gastrointestinal endoscopy as antral
gastritis secondary to prolonged NSAID use.
On general examination, her consciousness level was a
Glasgow coma scale (GCS) level of 14/15 with an ele-
vated blood pressure of 190/120 mmHg. Palms of her
hands revealed a blotchy palpable purpuric type of vaculi-
tic rash (Figure 1). Nervous system examination revealed
a clawed right hand in isolation without any other deficit
or abnormality (Figure 1). Fundi were normal. Remainder
of the systemic examination including the cardiovascular
and respiratory systems and abdomen was normal.
Electrolyte profile was normal, except for serum calcium
and phosphate which were ranged in the lower limit of an
accepted normal value [S.Ca2+- 2.13 mmol/L (2.1-2.55),
S.PO4
3--0.8 mmol/L (0.8-1.5)]. Repeated complete blood
counts (CBC) showed markedly elevated white cell count
[21.88 × 109/L (4–10)] with neutrophil predominance
(85.4 %) and a low haemoglobin value of 7.1 g/dL. All three
red cell indices [mean corpuscular volume −70.7 fL (80–
100), mean corpuscular haematocrit -21 pg (27–34), mean
corpuscular haematocrit concentration- 30 g/dL (32–36)]
were reduced. Blood picture demonstrated microcytic
hypochromic cells, polychromasia, target cells and poly-
morphonuclear leukocytosis. Platelet values and morph-
ology were normal. Coombs test was negative. Erythrocyte
sedimentation rate was elevated with a value of 130 mm
for the 1st hour as was the C – Reactive protein with a
value of 114 mg/L. Repeated values too were persistently
elevated. Iron studies revealed a reduced serum iron of
8 μg/dL (37–148), a total iron binding capacity of 260 μg/
dL (274–385) with an iron saturation of 3.1% (15–50) and
an elevated serum ferritin of 189 ng/mL (6–159). Liver
functions (coagulation profile and liver enzymes) and renal
functions were repeatedly normal. Blood and urine cultures
were negative but urinalysis repeatedly showed the pres-
ence of a significant number of red cells with protein in
the absence of casts. Features were not in favor of men-
ingitis or encephalitis to pursue an investigative path in
that direction. Anti-nuclear antibody (ANA) was weaklyalpable vasculitic rash on the palmar surface while the image on
Figure 3 CT brain: Computed tomography scan of the brain
taken on preliminary presentation showing bilateral occipital
lobe hypodensity and oedema.
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(anti-dsDNA), anti-cyclic citrulinated peptide (ACCP),
anti-neutrophil cytoplasmic antibodies (ANCA) P and
C, cryoglobulin and rheumatoid factor were all negative
with an elevated C3 complement level of 160 mg/dL with
a repeat value of 129 mg/dL (55–120), two weeks later.
Thyroid function tests were normal. Hepatitis screening
was negative. Skin biopsy revealed moderate vessel vascu-
litis and red cell extravasation with fibrinoid necrosis of
vessels (Figure 2).
Preliminary non contrast computed tomography of the
brain showed bilateral occipital lobe hypodensity coupled
with oedema (Figure 3). Magnetic resonance imaging re-
vealed bilateral occipital lobe involvement which had low
signal intensity on T1 and high intensity on T2 without
gadolinium enhancement (Figure 4). Electroencephalog-
raphy demonstrated gross background slowing in delta
range with continuous right-sided sharp slow complexes
suggestive of ongoing seizure discharges, indicating an
encephalopathic picture with right focal seizure dis-
charges (Figure 5). Nerve conduction study confirmed
isolated ulnar nerve involvement confirming mono-
neuopathy. Ultrasound abdomen revealed structurallyFigure 2 Biopsy findings: Histology demonstrates moderate
vessel vasculitis and fibrinoid necrosis with red cell extravasation.abnormal kidneys (right kidney measured 8.8 cm in length
and the left 8.9 cm) with irregular margins but preserved
cortico-medullary demarcation. Renal imaging studies con-
firmed the ultrasound findings (Figure 6). Renal artery
angiogram revealed the presence of micro aneurysms in
the right kidney vasculature (Figure 6). 2D echo was nor-
mal. Two months later the repeat magnetic resonance im-
aging revealed overall improvement, but with multiple
focal high intensity areas being noted on white matter of
corona radiata and persistence of a high intensity area on
the occipital cortex in the absence of post contrast en-
hancement (Figure 4).
We treated our patient symptomatically with antiemetics
and antihypertensives and controlled the seizures with di-
azepam satisfactorily. Blood pressure control was achieved
and vomiting subsided with a dramatic clinical improve-
ment. Seizures did not persist after the initial day of pres-
entation. Physiotherapy was initiated and continued for the
ulnar nerve palsy. Immunosuppressive therapy was initi-
ated for PAN and the patient showed good response with
reduction of inflammatory markers and normalization and
maintenance of blood pressure.
Discussion and conclusion
The classic history of seizures, altered behavior and vis-
ual disturbance along with brain imaging delineated a
diagnosis of PRES. There is variable opinion as to the
commonest presenting feature of PRES. Lee et al. in
their retrospective analysis stated encephalopathy to be
the commonest, though Garg considers seizures to
precede others and Fugate et al. found it to be the
(a) (b)
(c) (d)
Figure 4 Preliminary and reassessment MRI brain: (a), (c) are preliminary MRI images taken on presentation. (a) - T2 weighted shows
high signal intensity and (c) – T1 weighted shows low signal intensity involving the posterior occipital areas with cortical and subcortical regions.
(b), (d) are MRI images taken on reassessment showing improvement.
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the main features (encephalopathy, seizure, headache, vis-
ual disturbance) can be the presenting symptom [10-12].
Speculation exists as to the possible mechanisms resulting
in PRES, and there is no clear consensus regarding the
exact pathophysiological basis [2,13], and neither do most
authors comment on the basis of seizures. But vasogenic
oedema, which is seen in both hypo-perfusion and hyper-
perfusion could be considered the underlying pathophysi-
ology for the presentations in PRES, including seizures
[13,14]. Seizures are commonly generalized and multiple,
but can be focal in origin with secondary generalization
followed by prolonged altered consciousness, as was in
our patient [10,11]. Visual symptoms too are varied e.g.,
hemianopia, visual neglect, cortical blindness, Anton syn-
drome, blurred vision [1,10]. Though diplopia is not com-
mon it has been reported and can be explained if it
involved the brainstem [15]. Imaging usually (94%) reveals
symmetrical parieto-occipital lobe involvement, and ourpatient demonstrated symmetrically distributed occipi-
tal lobe changes typically seen on both CT and MRI
with associated generalised oedema (Figure 3). Though
frequent frontal lobe and to lesser extent cerebellum,
brain stem, basal ganglia, deep white matte and even the
splenium of the corpus callosum can be involved asym-
metrically [8,12]. There may be regional association of
presenting symptoms to the area afflicted by PRES,
however features such as seizures, headache, encephal-
opathy make up a spectrum seen in most presentations
and seizures are seen even when individual regions (in-
cluding isolated occipital lobes) were afflicted or when
multiple regions are affected together, this was clearly
demonstrated in the literature analysis of Leroux et al.
where presenting symptomology and afflicted radiological
areas of involvement of multiple cases of PRES were
reviewed [16]. The clinical findings and the history favored
a vasculitic picture. Investigational findings (elevated in-
flammatory markers and low total iron binding capacity
Figure 5 Preliminary EEG on presentation: EEG shows background delta range slowing with continuous right-sided sharp slow
complexes suggestive of ongoing seizure discharges.
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with ongoing inflammation. Imaging studies demonstrated
end organ damage involving the kidneys and brain. In the
absence of the common autoimmune causes (negative
serological findings) and ACR criteria being met for PAN
with typical histological finding with renal arterial im-
aging, a clinical diagnosis of PAN with PRES was made.
Posterior reversible encephalopathy syndrome is a
situation that is not very often thought of by clinicians
[17]. High level of clinical suspicion is required to in-
clude PRES into the differential diagnosis and one may
only arrive at the diagnosis following exclusion of com-
moner acute neurological conditions such as encephal-
itis, from history and clinical examination. Cerebrospinal
fluid analysis may have to be considered if indicated, fol-
lowing initial CT imaging of brain. However CT imaging
being the primary investigation of choice, when needed
complemented by an MRI provides strong evidence to
arrive at a diagnosis of PRES. In our clinical scenario the
diagnosis of PRES was made with the typical imaging
findings. Angiography studies of the brain vasculaturehave shown common occurrence of vasculopathy in the
form of vasoconstriction, vasodilation and string of bead
appearance supporting hypo-perfusion as the cause for
PRES with hypertension occurring as a protective coun-
ter mechanism [13]. Unfortunately we were unable to do
magnetic resonance angiogram of the brain for our pa-
tient. Though it would not have changed the final diag-
nosis or treatment, it would have given further insight
into the complexities of the origin of PRES and changes
that may have been found in the vessels when hyperten-
sion was already present rather than being a protective
responsive rise, as the elevated blood pressure being at-
tributable to PAN in our patient, favors the mechanism
of resultant auto-regulatory failure and hyper-perfusion
induced PRES. In most cases PRES is benign, the hallmark
being its reversibility. However permanent neurological
injury can occur especially when treatment is delayed
[11,18], and in a background of preexistent coagulation
abnormalities even intra-cerebral haemorrhage and sub-
arachnoid haemorrhage have been reported [19]. In PRES,
symptomatic treatment when instituted early results in
Figure 6 Renal imaging: Row 1: Computed tomography of the abdomen demonstrates structurally abnormal kidneys with irregular
contours, suggesting infarction occurring secondary to PAN causing architectural change. Row 2: Digital subtraction angiogram of the
kidneys demonstrates early aneurysms on the right renal vasculature.
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the absence of a positive diagnosis, PRES may be missed,
especially since neuroimaging changes of this condition
have been known to resolve within days [1]. Classically
normalization of imaging abnormalities lags behind
clinical recovery by weeks or even years [11]. Seizures
are usually transient and do not necessitate long term
antiepileptic therapy; however rarely chronic epilepsy
can occur [11,20].
Since PRES is usually subsequent to a primary aetio-
pathological process a search for such systemic disease
should be initiated. Polyarteritis nodosa by itself is a rare
disease. The exclusion of more common autoimmune
disease as a possible primary aetiopathological process
requires the availability of sero-diagnostic tests. The
diagnosis of PAN requires a high degree of suspicion as
there is no single investigation that clinches the diagno-
sis conclusively. In our patient the criteria to suspect
PAN was met [9] in the presence of arthralgia, weight
loss, mononeuropathy, diastolic blood pressure exceed-
ing 90 mmHg and was strengthened by the skin biopsyevidence of moderate vessel vasculitis and renal arterial
imaging demonstrating aneurysms. PAN classically spares
the aorta, its tributaries and the lung but can affect any
other organs [21]. Renal involvement is seen in about 70%
of affected subjects [22]. Our patient demonstrated struc-
turally abnormal kidney architecture. Small persistent
infarctions with resultant scarring can alter the renal con-
tour and produce an irregular morphological appearance
as was seen in our patient [23]. Digital subtraction angio-
gram revealed aneurysms of the right renal vessels further
signifying that our patient has renal involvement. Other
classic vessel abnormalities of medium and small vessels
include perfusion defects and delayed emptying of the
commonly affected vessels of the kidney e.g., arcuate and
interlobular arteries and arterioles [23,24]. PAN can also
be staged histologically according to biopsy findings as
acute, sub-acute and chronic stages. Since fibrinoid necro-
sis of vessels is classically seen late and was histologically
demonstrated in our patient’s skin biopsy, we could as-
sume that she belonged to the chronic stage of the disease.
Central nervous system involvement is also considered a
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athy by Provenzale et al. [25]. Biochemically she had iron
deficiency anaemia and anaemia of chronic disease, this
coupled together with neurological involvement and hist-
ology finding suggests long standing disease.
Prior to its new classification as PRES, Rosenberg et al.
in 1990 have also reported a very similar presenting case
of PAN to that of ours [26], possibly implying that cases in
the past may have been overlooked and PAN with PRES
under-reported. However the situation of PAN resulting
in PRES is still uncommon. The atypical presentation of
both PAN and PRES, failure to identify each entity, and
the lack of availability of sero-diagnostic and imaging
studies can result in clinical confusion, delaying early
diagnosis and treatment. All of these factors may pos-
sibly be why so few cases of PAN and PRES have been
reported. In our patient each initial symptom was treated
in isolation resulting in drug induced complications while
overlooking the overall diagnosis. This reiterates the need
for a high level of suspicion for a unifying diagnosis of
PAN to avoid isolated symptomatic treatment. This young
woman most likely had PAN from the outset causing most
of her earlier ailments. The delay in her diagnosis result-
ing in evolution of the disease to its advanced stage
resulting in elevated blood pressure culminated in a
presentation of PRES.
Conclusions
Posterior reversible encephalopathy syndrome requires a
high degree of suspicion and should always come into
the differential when faced with the classic pattern of
symptoms in such an acute presentation. It is a diagnosis
which should not be missed and should prompt a thor-
ough search through history, examination and investiga-
tions for an aetiopathological cause and consideration
should be given even for the less frequent associations.
When a vasculitic picture is suggested by the history and
examination, even rarer causes should be considered for
timely intervention to be instituted.
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